Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy (Q44599816)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 1, 2003

Language	Label	Description	Also known as
English	Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy	scientific article published on October 1, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy (English)

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

internal medicine

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

author name string

Munehiro Kitada

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Daisuke Koya

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Toshiro Sugimoto

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Motohide Isono

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Shin-ichi Araki

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Atsunori Kashiwagi

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Masakazu Haneda

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

http://hw-f5-diabetes.highwire.org/content/52/10/2603.full.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514646

15 March 2024

https://journals.org/diabetes/diabetes/article-pdf/52/10/2603/370665/db1003002603.pdf

Portable Document Format

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

https://diabetesjournals.org/diabetes/article-pdf/52/10/2603/370665/db1003002603.pdf

Portable Document Format

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2603-2614

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Cell transformation by the superoxide-generating oxidase Mox1

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.1038/43459

15 July 2023

Oxidative damage to DNA in diabetes mellitus

1

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

New biomarker evidence of oxidative DNA damage in patients with non‐insulin‐dependent diabetes mellitus

2

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

3

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria

4

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

5

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite

9

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Enhancement of glomerular heme oxygenase-1 expression in diabetic rats

10

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

12

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

13

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II

15

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo

16

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate

19

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

A novel superoxide-producing NAD(P)H oxidase in kidney

20

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways

21

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

23

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

24

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

25

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats

26

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats

28

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells

29

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Cellular antioxidant effects of atorvastatin in vitro and in vivo

30

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction

31

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney

32

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy

33

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

34

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Involvement of protein kinase C beta 2 in c-myc induction by high glucose in pancreatic beta-cells

35

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical

36

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage

37

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems

38

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase

39

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

40

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Angiotensin II induces superoxide anion production by mesangial cells

41

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1.

43

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Requirement for generation of H2O2 for platelet-derived growth factor signal transduction

44

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Cyclic strain induces an oxidative stress in endothelial cells

45

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase

46

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats

47

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes

48

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice

49

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes

51

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

52

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation

53

1 reference

10.2337/DIABETES.52.10.2603

https://api.crossref.org/works/10.2337/DIABETES.52.10.2603

15 March 2024

Identifiers

10.2337/DIABETES.52.10.2603

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44599816&oldid=2102384609"